Chr. Olesen Synthesis Overview
- Founded
- 2011
- Status
- Private
- Latest Deal Type
- Series A
- Latest Deal Amount
- $11.3M
- Investors
- 1
Chr. Olesen Synthesis General Information
Description
Manufacturer of active pharmaceutical ingredients (APIs) and advanced intermediates designed to produce controlled substances comprising semi-synthetic opioids. The company is focused on controlled substances and molecules like Buprenorphine, Codeine Phosphate, Dexamfetamine, Hydromorphone and Lisdexamfetamine and also offers an election of other APIs like Pramipexole, Risedronate, Terbinafine and Tolfenamic Acid as well as advanced intermediates, enabling pharmaceutical clients to avail advanced intermediates and APIs.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
- Kanalholmen 8-12
- 2650 Hvidovre
- Denmark
+45 36 00 00 00
Chr. Olesen Synthesis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 01-Oct-2015 | $11.3M | 000.00 | Completed | Generating Revenue |
Chr. Olesen Synthesis Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Thomas Moestrup | Chief Executive Officer | ||
| Erik Fischer | Head, API Development | ||
| Lone Nielsen | Finance & Administration Manager |
Chr. Olesen Synthesis Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| James Gale | Signet Healthcare Partners | Board Member | 000 0000 |
| Mads Olesen | Chr. Olesen Synthesis | Chairman | 000 0000 |
Chr. Olesen Synthesis Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Signet Healthcare Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 |
Chr. Olesen Synthesis Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 | 01-Jan-2011 | 000000000 | Distributors (Healthcare) |
Chr. Olesen Synthesis Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000 | 01-Jan-2011 | 000000000 | Completed |
|